NIAID BAA Outlines New Funding Opportunities for the Development of Vaccines, Therapeutics, and Diagnostics
The National Institute of Allergy and Infectious Diseases (“NIAID”) recently published Broad Agency Announcement (‘BAA”) No. HHS-NIH-NIAID-BAA2023-1, which provides funding opportunities for the advancement of promising candidate vaccines, therapeutics, and diagnostics for Biodefense, Emerging Infectious Diseases, and Pandemic Preparedness. Four Areas for NIAID Funding 1. Research Area 001 – Development of Vaccine Candidates for Biodefense […]